NCT03514329View on ClinicalTrials.gov

Vapor Ablation for Localized Cancer Lesions

NANot yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 1, 2026

Primary Completion Date

March 30, 2028

Study Completion Date

June 30, 2028

Conditions
Non Small Cell Lung CancerMetastatic Lung CancerLung Cancer
Interventions
DEVICE

Bronchoscopic Thermal Vapor Ablation

Vapor (steam) is infused into the targeted region for 8 seconds at a precisely controlled flow rate and power.

Trial Locations (2)

Unknown

Otto-Wagner Hospital, Vienna

I-60020

Azienda Ospedaliero - Universitaria, Ancona

All Listed Sponsors
lead

Uptake Medical Technology, Inc.

INDUSTRY